Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01337466 · ClinicalTrials.gov registry record · Phase 1
Biodistribution and Dosimetry Evaluation of [124I]FIAU
A Phase 1 study, sponsored by BioMed Valley Discoveries.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01337466 is a Phase 1 study that has completed, run by BioMed Valley Discoveries. The registered enrollment target is 12 participants.
The verdict
NCT01337466, a Phase 1 study, has completed, sponsored by BioMed Valley Discoveries.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
This protocol will evaluate the biodistribution and dosimetry of \[124I\]FIAU in both healthy volunteers and patients with prosthetic joint infections. This pilot study will also investigate the safety and tolerability of \[124I\]FIAU.
Interventions
- RADIATION [124I]FIAU
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2010-12 |
| Est. Completion | 2013-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01337466
The ClinicalTrials.gov registry entry for NCT01337466 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioMed Valley Discoveries, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [124I]FIAU is the first listed.
NCT01337466 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01337466 about?
NCT01337466 is a clinical study titled "Biodistribution and Dosimetry Evaluation of [124I]FIAU". This protocol will evaluate the biodistribution and dosimetry of \[124I\]FIAU in both healthy volunteers and patients with prosthetic joint infections. This pilot study will also investigate the safety and tolerability of \[124I\]FIAU.
What is the current status of trial NCT01337466?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2010-12. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01337466?
The interventions under investigation include: [124I]FIAU (RADIATION).
Who is sponsoring clinical trial NCT01337466?
This trial is sponsored by BioMed Valley Discoveries, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.